Literature DB >> 33459949

miR-362-3p Targets Orosomucoid 1 to Promote Cell Proliferation, Restrain Cell Apoptosis and Thereby Mitigate Hypoxia/Reoxygenation-Induced Cardiomyocytes Injury.

Meijing Shi1, Xiuru Ma2, Qian Yang3, Wenjing Wang3, Xinning Li3, Xuelian Song1,3, Yingxiao Li3, Yuetao Xie3, Yi Dang4.   

Abstract

This study aimed to investigate the mechanism of how miR-362-3p/orosomucoid 1 (ORM1) involved in hypoxia/reoxygenation (H/R)-induced cardiomyocytes injury. Based on data obtained from Gene Expression Omnibus (GEO) database, we revealed that ORM1 was highly expressed and positively correlated with the expression of inflammatory factors (MAPK1, MAPK3, IL1B and CASP9). miR-362-3p was identified as an upstream regulatory miRNA of ORM1 and negatively modulated the mRNA and protein expression levels of ORM1 in H/R-injured cardiomyocytes. Moreover, we found that miR-362-3p was downregulated in cardiomyocytes injured by H/R. The promoting influence of miR-362-3p mimic on the proliferation and the inhibitory effect of miR-362-3p mimic on the apoptosis of H/R-stimulated cardiomyocytes were eliminated by overexpression of ORM1. Furthermore, miR-362-3p affected the expression of MAPK1, MAPK3, IL1B and CASP9 in H/R-injured cardiomyocytes through targeting ORM1. Our outcomes illustrated that miR-362-3p exhibited a protective influence on H/R-induced cardiomyocytes through targeting ORM1.

Entities:  

Keywords:  Apoptosis; Biomarker; Inflammatory factors; Orosomucoid 1; miR-362-3p

Mesh:

Substances:

Year:  2021        PMID: 33459949     DOI: 10.1007/s12012-020-09631-0

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  42 in total

Review 1.  Acute phase proteins in ruminants.

Authors:  F Ceciliani; J J Ceron; P D Eckersall; H Sauerwein
Journal:  J Proteomics       Date:  2012-04-11       Impact factor: 4.044

2.  Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.

Authors:  Dai Chihara; Jason R Westin; Yasuhiro Oki; Mohamed A Ahmed; Bryan Do; Luis E Fayad; Fredrick B Hagemeister; Jorge E Romaguera; Michelle A Fanale; Hun J Lee; Francesco Turturro; Felipe Samaniego; Sattva S Neelapu; M Alma Rodriguez; Nathan H Fowler; Michael Wang; Richard E Davis; Loretta J Nastoupil
Journal:  Cancer       Date:  2016-06-28       Impact factor: 6.860

3.  Global progress in prevention of cardiovascular disease.

Authors:  Shanthi Mendis
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 4.  Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Xiao-Qiang Cong; Ying Li; Xin Zhao; Yan-Jian Dai; Ya Liu
Journal:  J Cardiovasc Transl Res       Date:  2015-05-08       Impact factor: 4.132

Review 5.  Fibroblasts in myocardial infarction: a role in inflammation and repair.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2013-12-07       Impact factor: 5.000

6.  The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.

Authors:  Fei Li; Zhe Yu; Pengliang Chen; Guangzheng Lin; Tieqiu Li; Lina Hou; Yuejun Du; Wanlong Tan
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

7.  The acute phase protein orosomucoid 1 is upregulated in early lactation but does not trigger appetite-suppressing STAT3 signaling via the leptin receptor.

Authors:  M M McGuckin; S L Giesy; A N Davis; M A Abyeta; E A Horst; S Saed Samii; Y Zang; W R Butler; L H Baumgard; J W McFadden; Y R Boisclair
Journal:  J Dairy Sci       Date:  2020-03-27       Impact factor: 4.034

8.  Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction.

Authors:  Kaveh Eghbalzadeh; Leena Georgi; Theresa Louis; Haizhi Zhao; Ugur Keser; Carolyn Weber; Martin Mollenhauer; Andreas Conforti; Thorsten Wahlers; Adnana Paunel-Görgülü
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

9.  Self-reported sleep quality and depression in post myocardial infarction patients attending cardiology outpatient clinics in Oman.

Authors:  Rashid Said Saif Almamari; Joshua Kanaabi Muliira; Eilean Rathinasamy Lazarus
Journal:  Int J Nurs Sci       Date:  2019-06-21

10.  Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan.

Authors:  Wang-Qing Chen; Yan Shu; Qing Li; Lin-Yong Xu; Mary W Roederer; Lan Fan; Lan-Xiang Wu; Fa-Zhong He; Jian-Quan Luo; Zhi-Rong Tan; Yi-Jing He; Hong-Hao Zhou; Xiang Chen; Wei Zhang
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more
  2 in total

1.  Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis.

Authors:  Congqi Hu; Zhao Dai; Jia Xu; Lianyu Zhao; Yanping Xu; Meilin Li; Jiahui Yu; Lu Zhang; Hui Deng; Lijuan Liu; Mingying Zhang; Jiarong Huang; Linping Wu; Guangxing Chen
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

2.  Role of miRNA-324-5p-Modified Adipose-Derived Stem Cells in Post-Myocardial Infarction Repair.

Authors:  Zhou Ji; Chan Wang; Qing Tong
Journal:  Int J Stem Cells       Date:  2021-08-30       Impact factor: 2.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.